During the past decade, Forest Hills Dermatology Group conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forest Hills Dermatology Group" #1 sponsor was "Amgen" with 3 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Akros Pharma Inc." with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forest Hills Dermatology Group" #1 collaborator was "Hexal AG" with 1 trials as a collaborator and "Innovaderm Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Forest Hills Dermatology Group" are "Atopic Dermatitis" (5 trials), "Psoriasis" (4 trials), "Plaque Psoriasis" (2 trials), "Alopecia Areata" (1 trials) and "Chronic Spontaneous Urticaria" (1 trials). Many other conditions were trialed in "Forest Hills Dermatology Group" in a lesser frequency.

Most popular intervention types in "Forest Hills Dermatology Group" are "Drug" (13 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apremilast" (2 trials), "Ruxolitinib cream" (2 trials), "Apremilast (CC-10004)" (1 trials) and "Deoxycholic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forest Hills Dermatology Group" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Forest Hills Dermatology Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Forest Hills Dermatology Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Forest Hills Dermatology Group, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Forest Hills Dermatology Group has several departments that took part in Clinical trials: "Forest Hills Dermatology Group" - 10 trials